Experts explore the evolving landscape of ovarian cancer treatment, emphasizing the need for targeted therapies and biomarker ...

Scientists are developing a new device that fits inside a menstrual pad and checks for "biomarkers" of disease in period ...

Genetic testing could prevent you from ever having ovarian cancer. “The only way to do that is to offer testing to people ...

Corcept Therapeutics’ relacorilant, a selective glucocorticoid receptor antagonist (SGRA), is emerging as a novel therapeutic ...

The addition of relacorilant to nab-paclitaxel significantly extended survival for women with platinum-resistant ovarian ...

Dr Leearne Hinch, CEO of INOVIQ (ASX:IIQ), discusses the company’s progress in developing a screening test for ovarian cancer—an area with no currently approved screening options.

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to ...